Researchers Seek To Identify and Establish New Standards of Care
PALO ALTO, CA / ACCESSWIRE / May 2, 2023 / Lynx.MD, a leading medical data intelligence platform, today announced a new partnership with Prometheus Laboratories Inc. (“Prometheus”) and Gastro Health to securely unite real-world clinical data for retrospective analysis of inflammatory bowel disease (IBD) biologic treatment. The partnership will bring together 10-years of de-identified IBD clinical laboratory data and patient data, using the Lynx Trusted Data Environment, to research and demonstrate the value of the Prometheus Anser® IFX therapeutic drug monitoring test to improve patient clinical outcomes and reduce overall healthcare costs in IBD patient management.